4//SEC Filing
Tansey Casey M 4
Accession 0001628280-25-039730
CIK 0001464521other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:00 PM ET
Size
54.9 KB
Accession
0001628280-25-039730
Insider Transaction Report
Form 4
Heartflow, Inc.HTFL
Tansey Casey M
Director
Transactions
- Conversion
Series C Preferred Stock
2025-08-11−21,295→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (21,295 underlying) - Conversion
Series D Preferred Stock
2025-08-11−2,586→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (2,586 underlying) - Conversion
Convertible Promissory Note
2025-08-11−51,736→ 0 total(indirect: By U.S. Venture Partners X, L.P.)Exercise: $15.20→ Common Stock (51,736 underlying) - Conversion
Convertible Promissory Note
2025-08-11−16,447→ 0 totalExercise: $15.20→ Common Stock (16,447 underlying) - Conversion
Common Stock
2025-08-11+98,303→ 98,303 total(indirect: By USVP X Affiliates, L.P.) - Conversion
Common Stock
2025-08-11+16,447→ 16,447 total - Conversion
Series B-1 Preferred Stock
2025-08-11−10,560→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (10,560 underlying) - Conversion
Series B-1 Preferred Stock
2025-08-11−7,040→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (7,040 underlying) - Conversion
Series D Preferred Stock
2025-08-11−10,106→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (10,106 underlying) - Conversion
Common Stock
2025-08-11+3,072,759→ 3,072,759 total(indirect: By U.S. Venture Partners X, L.P.) - Conversion
Series B-1 Preferred Stock
2025-08-11−220,052→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (220,052 underlying) - Conversion
Series B-1 Preferred Stock
2025-08-11−330,078→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (330,078 underlying) - Conversion
Series B-2 Preferred Stock
2025-08-11−220,052→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (220,052 underlying) - Conversion
Series B-2 Preferred Stock
2025-08-11−330,078→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (330,078 underlying) - Conversion
Series B-2 Preferred Stock
2025-08-11−7,040→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (7,040 underlying) - Conversion
Series D Preferred Stock
2025-08-11−323→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (323 underlying) - Conversion
Convertible Promissory Note
2025-08-11−1,655→ 0 total(indirect: By USVP X Affiliates, L.P.)Exercise: $15.20→ Common Stock (1,655 underlying) - Award
Stock Option
2025-08-07+47,420→ 47,420 totalExercise: $19.00Exp: 2035-08-07→ Common Stock (47,420 underlying) - Conversion
Series B-2 Preferred Stock
2025-08-11−10,560→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (10,560 underlying) - Conversion
Series F Preferred Stock
2025-08-11−1,164,179→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (1,164,179 underlying) - Conversion
Series F Preferred Stock
2025-08-11−37,244→ 0 total(indirect: By USVP X Affiliates, L.P.)→ Common Stock (37,244 underlying) - Conversion
Series C Preferred Stock
2025-08-11−665,623→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (665,623 underlying) - Conversion
Series D Preferred Stock
2025-08-11−80,855→ 0 total(indirect: By U.S. Venture Partners X, L.P.)→ Common Stock (80,855 underlying)
Footnotes (7)
- [F1]Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
- [F2]Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
- [F3]Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
- [F4]Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
- [F5]Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.
- [F6]Presidio Management Group X, L.L.C. ("PMG X") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F7]The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.
Documents
Issuer
Heartflow, Inc.
CIK 0001464521
Entity typeother
Related Parties
1- filerCIK 0001474322
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 9:00 PM ET
- Size
- 54.9 KB